Alembic Pharma gains after receiving USFDA nod for Betamethasone Valerate Foam

Alembic Pharmaceuticals jumped 2.25% to Rs 1,125.35 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Betamethasone Valerate Foam.